Analysis of:
Pfizer To Launch Antiretroviral Maraviroc In July After FDA Tests Conclude, Official Says (www.medicalnewstoday.com)
Maraviroc will aid decrease HIV drug resistence. Because maraviroc's mechanism of action is different from the other antiretrovirals, its use can help those patients with HIV resistant mutations.
Analysis of:
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis (pharmalive.com)
I am not sure that 4-aminopyridine, a long known drug, will efectively improve walking. As important as the walking ability are other clinical features of MS, e.g. ataxia, dementia or bladder dysfunction. This should also be tested.
Analysis of:
U.S. urges strongest warning on 2 diabetes drugs (www.iht.com)
The recent meta-analysis published in the New England Journal of Medicine suggests an increased risk of myocardial infarction in patients taking rosiglitazone (Avandia). Additionally, there was an increased risk of death, but it did not reach stastistical significance. Black-box warnings are...
Analysis of:
Avicena Highlights Key Collaborators in Amyotrophic Lateral Sclerosis (ALS) Dose Escalation Study (pharmalive.com)
There is not much information of the drug ALS-02 in the paper. The term neuroprotection is defined not very well and describes a great number of different molecular mechanisms. The low number of patients will not allow implications for clinical efficacy.
Analysis of:
New Treatment Offers Relief from Chronic Back Pain - Study Suggests Safe Treatment for a Variety of Conditions (www.medicalnewstoday.com)
(1) Chronic back pain is a challenge to treat with limited options. (2) The emergence of new therapies to help support efforts at physiotherapy are certainly hopeful signs for those with refractory pain. (3) There are concerns about this specific treatment, PRF.
Analysis of:
New Treatment Offers Relief from Chronic Back Pain - Study Suggests Safe Treatment for a Variety of Conditions (www.medicalnewstoday.com)
(1) Chronic back pain is a challenge to treat with limited options. (2) The emergence of new therapies to help support efforts at physiotherapy are certainly hopeful signs for those with refractory pain. (3) There are concerns about this specific treatment, PRF.
Analysis of:
New Test May Allow For Rapid Detection Of Salmonella In Meat (www.medicalnewstoday.com)
PCR analysis of meat for Salmonella was compared to traditional culture methods The PCR technique showed a relatively high sensitivity and specificity for the organism much more rapidly
Analysis of:
Bayer's Betaseron found efficacious in multiple sclerosis patients (www.spiritindia.com)
The most recently reported data on Betaseron highlight the usefulness of early treatment of multiple sclerosis (MS) patients. These results allow to widen significantly the number of potential users of Betaseron. They are consistent with the results previously obtained with Avonex, one of...
Analysis of:
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients (www.pipelinereview.com)
Telbivudine is a new option of treatment for patients with chronic hepatitis B.In the United States, approximately 1.2 million persons have chronic hepatitis B virus (HBV) infection and are sources for HBV transmission to others. Two billion people infected worldwide, and 350 million suffering...
Analysis of:
Brazil Bypasses Patent on U.S. AIDS Drug (www.reuters.com)
Newer, more efficacious antiretrovirals are emerging.Older treatments must be open in order to be competitive and continue in the market.